A Single-blind, Randomized, Parallel-group, Multi-center Phase 2 Study to Determine the Efficacy and Safety of TissueGene-C Mixed With Fibrin-glue in Patients With Degenerative Arthritis
Phase of Trial: Phase II
Latest Information Update: 09 Sep 2019
Price : $35 *
At a glance
- Drugs Tonogenchoncel-L (Primary) ; Fibrin
- Indications Arthritis
- Focus Therapeutic Use
- Sponsors Kolon Life Science
- 20 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Jun 2014 Planned End Date changed from 1 Jun 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov record.
- 09 Jan 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.